About: Screening testing for SARS‐CoV‐2 upon admission to rehabilitation hospitals in a high COVID‐19 prevalence community

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Screening testing for SARS‐CoV‐2 upon admission to rehabilitation hospitals in a high COVID‐19 prevalence community Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Screening testing for SARS‐CoV‐2 upon admission to rehabilitation hospitals in a high COVID‐19 prevalence community
Creator	Dawson, Amanda Gans, Bruce Hammerman, Samuel Kirshblum, Steven Lopreiato Bsn, Maeve Mph, Gabrielle Pomeranz, Bruce
Source	Medline; PMC
abstract	INTRODUCTION: While planning for the care of COVID‐19 patients during the pandemic crisis has dominated the focus of leaders of inpatient rehabilitation facilities (IRF), patients with injuries/ illnesses unrelated to COVID‐19 continue to need inpatient rehabilitation admission. To maintain a safe environment for all patients and staff, we established an admission screening plan of testing for SARS‐CoV‐2 to determine the presence of asymptomatic patients who were infected with the virus upon admission. OBJECTIVE: To determine the prevalence of patients who test positive for SARS‐CoV‐2 but were presumed to be COVID‐19 negative at the time of admission to IRF in New Jersey. DESIGN: Retrospective analysis of SARS‐CoV‐2 testing results. SETTING: Four freestanding IRFs in New Jersey operated as one system. PATIENTS: All (N=103) patients sequentially admitted from April 4 –27, 2020 with no symptoms or evidence of COVID‐19 disease at the time of transfer from the acute hospital. INTERVENTIONS: Specimens were collected for SARS‐CoV‐2 analysis at the time of admission to the IRF and patients were monitored for subsequent symptom development over the next 14 days. MAIN OUTCOME MEASURES: Results of SARS‐CoV‐2 testing upon admission and evidence of development of clinical signs or symptoms of COVID‐19. RESULTS: Seven asymptomatic persons (6.8% of admissions) without clinical signs/symptoms of COVID‐19 tested positive on admission. Of these, five developed symptoms of COVID‐19, with a mean onset of 3.2 (range of 2‐5) days. Five additional patients became symptomatic and tested positive within the next 3‐10 days (mean of 5.2 days). Overall, 11.6% of admissions (12/103) had a positive test within 14 days of admission. CONCLUSIONS: Admission testing to post‐acute centers for SARS‐CoV‐2 can help identify pre‐symptomatic or asymptomatic individuals, especially in areas where COVID‐19 is prevalent. Negative results however, do not preclude COVID‐19 and should not be used as the sole basis for patient management decisions. This article is protected by copyright. All rights reserved.
has issue date	2020-07-23(xsd:dateTime)
bibo:doi	10.1002/pmrj.12454
bibo:pmid	32700434
has license	no-cc
sha1sum (hex)	8bac40afc1fd442bec1a8cbd4f059f5a9709655d
schema:url	https://doi.org/10.1002/pmrj.12454
resource representing a document's title	Screening testing for SARS‐CoV‐2 upon admission to rehabilitation hospitals in a high COVID‐19 prevalence community
has PubMed Central identifier	PMC7404891
has PubMed identifier	32700434
schema:publication	PM R
resource representing a document's body	covid:8bac40afc1fd442bec1a8cbd4f059f5a9709655d#body_text
is schema:about of	named entity 'focus' named entity 'pandemic' named entity 'dominated' named entity 'SARS-CoV-2' named entity 'INTRODUCTION' named entity 'CONTINUE' named entity 'CRISIS' named entity 'COVID-19' named entity 'testing' named entity 'asymptomatic patients' named entity 'COVID' named entity 'SARS-CoV-2' named entity 'pre-symptomatic' named entity 'signs and symptoms' named entity 'COVID' named entity 'IRFs' named entity 'IRFs' named entity 'IRFs' named entity 'unexplained fever' named entity 'IRFs' named entity 'asymptomatic' named entity 'COVID-19' named entity 'infection control' named entity '5.2' named entity 'spinal cord injury' named entity 'RT-PCR' named entity 'acute care' named entity 'risk factor' named entity 'PPE' named entity 'March 11' named entity 'COVID' named entity 'COVID-19' named entity 'asymptomatic' named entity 'SARS-CoV-2' named entity 'RT-PCR' named entity 'COVID' named entity 'acute hospital' named entity 'tested positive' named entity 'United States' named entity 'inpatient rehabilitation' named entity 'IRFs' named entity 'COVID-19' named entity 'inpatient rehabilitation' named entity 'NYC' named entity 'COVID-19' named entity 'false negative' named entity 'SARS-CoV-2' named entity 'reverse transcriptase polymerase chain reaction' named entity 'ventilator' named entity 'acute care' named entity 'acute care facility' named entity 'tested positive' named entity 'false negatives' named entity 'SARS-CoV-2' named entity 'COVID-19' named entity 'COVID-19' named entity 'SARS-CoV-2' named entity 'SAS' named entity 'SARS-CoV-2' named entity 'COVID-19' named entity 'IRFs' named entity 'asymptomatic' named entity 'pneumonia' named entity 'electronic medical record' named entity 'Demographic factors' named entity 'prevent the spread' named entity 'post-acute' named entity 'IRFs' named entity 'SARS-CoV-2' named entity 'virus' named entity 'COVID' named entity 'tested positive for COVID-19' named entity 'respiratory distress' named entity 'COVID' named entity 'New York City'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software